Factors influencing clinical course and histological findings in children with chronic hepatitis B

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 12, 2009, Pages 1400-1406

  Mozer Lisewska, Iwona ^a   Mania, Anna ^a   Słuzewski, Wojciech ^a   Kemnitz, Paweł ^a   Prusinowska, Joanna ^a   Kowala Piaskowska, Arleta ^a   Figlerowicz, Magdalena ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Children; Clinical course; Grading; Hepatitis B; Staging

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; HEPATITIS B; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; LIVER FIBROSIS; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SEROCONVERSION;

ADOLESCENT; AGE FACTORS; ALANINE TRANSAMINASE; BIOPSY; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS B, CHRONIC; HUMANS; INFANT; LIVER; LIVER CIRRHOSIS; MALE; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 77950191508     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328317f1fe     Document Type: Article

References (25)

1. Chang MH. Chronic hepatitis virus infection in children. J Gastroeneterol Hepatol 1998; 13: 541-548.
2. Lebensztejn DM, Kaczmarski M, Sobaniec - łotowska M, Barwijuk-Machaa M. Blind liver biopsy in children - diagnostic significance and complications in authors' own material. Med Sci Monit 2000; 6: 1155-1158.
3. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-435.
4. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Sheuer PJ. Classification of chronic hepatitis: diagnosis, grading ad staging. Hepatology 1994; 19: 1513-1520.
5. Ishak KG, Baptista A, Bianchi L, Callea F, De Groote J, Gudot J, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-699.
6. Desmet VJ. Scoring chronic hepatitis. J Hepatology 2003; 38: 382-386.
7. Fattovich G. Natural history of hepatitis B. J Hepatol 2003; 39: S50-S58.
8. Fattovich G, Rugge M, Brollo L, Pontisso P, Noventa F, Guido M, et al. Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B. Hepatology 1986; 6: 167-172.
9. Bortolotti F, Jara P, Crivellaro C, Hierro L, Cadrobbi P, Frauca E, et al. Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period. J Hepatol 1998; 29: 184-190.
10. Hsu YS, Chien RN, Yeh CT, Sheen IS, Chiou HY, Chu CM, et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 2002; 35: 1522-1527.
11. Bortolotti F, Cadrobbi P, Crivellaro C, Guido M, Rugge M, Noventa F, et al. Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood. Gastroenterology 1990; 99: 805-810.
12. Chang MH, Chen PJ, Chen JY, Lai MY, Hsu HC, Lian DC, et al. Hepatitis B virus integration in hepatitis B virus-related hepatocellular carcinoma in childhood. Hepatology 1991; 13: 316-320.
13. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997; 336: 1855-1859.
14. Perrillo RP. Antiviral therapy of chronic hepatitis B: past, present and future. J Hepatol 1993; 17: 56-63.
15. Buti M, Esteban R. Drugs in development for hepatitis B. Drugs 2005; 65: 1451-1460.
16. Jonas MM, Mizerski J, Badia IB, Areias JA, Schwarz KB, Little NR, et al. Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J Med 2002; 346: 1706-1713.
17. Sokal EM, Bortolotti F. Update on prevention and treatment of viral hepatitis in children. Curr Opin Pediatr 1999; 11: 384-389.
18. Minola E, Prati D, Suter F, Maggiolo F, Caprioli F, Sonzogni A, et al. Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C. Blood 2002; 99: 4588-4591.
19. Sokal EM, Conjeevaram HS, Roberts EA, Alvarez F, Bern EM, Goyens P, et al. Interferon alfa therapy for chronic hepatitis B in children: a multinational randomized controlled trial. Gastroenterology 1998; 114: 988-995.
20. Bortolotti F, Jara P, Barbera C, Gregorio GV, Vegntete A, Zancan L, et al. Long term effect of alpha interferon in children with chronic hepatitis B. Gut 2000; 46: 715-718.
21. Iorio R, Giannattasio A, Cirillo F, D'Alessandro L, Vegnente A. Long-term outcome in children with chronic hepatitis B: a 24-year observation period. Clin Infect Dis 2007; 45: 943-949.
22. Bortolotti F, Guido M, Bartolacci S, Cadrobi P, Crivellaro C, Noventa F, et al. Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study. Hepatology 2006; 43: 556-562.
23. Feld JJ, Ayers M, El-Ashry D, Mazzulli T, Tellier R, Heathcote EJ. Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B. Hepatology 2007; 46: 1057-1070.
24. Lin CL, Liao LY, Liu CJ, Yu MW, Chen PJ, Lai MY, et al. Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels. Hepatology 2007; 45: 1193-1198.
25. Fujisawa T, Komatsu H, lnui A, Sogo T, Miyagawa Y, Fujitsuka S, et al. Long- term outcome of chronic hepatitis B in adolescents or young adults in follow-up from childhood. J Pediatr Gastroenterol Nutr 2000; 30: 201-206.